Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,239 | -48,133 | -31,632 | -18,485 | -6,671 |
| Depreciation Amortization | 264 | 566 | 297 | 188 | 71 |
| Accounts payable and accrued liabilities | 1,144 | 4,829 | 2,267 | 1,364 | 208 |
| Other Working Capital | 927 | 4,663 | 2,247 | 1,072 | 181 |
| Other Operating Activity | 1,597 | 4,349 | 4,429 | 2,940 | 1,714 |
| Operating Cash Flow | $-13,307 | $-33,726 | $-22,392 | $-12,921 | $-4,497 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -539 | -181 | -146 | -59 | -29 |
| Purchase Of Investment | -8,188 | -95,376 | -34,593 | -31,852 | -29,345 |
| Sale Of Investment | 14,828 | 22,239 | 12,160 | 2,985 | N/A |
| Investing Cash Flow | $6,101 | $-73,318 | $-22,579 | $-28,926 | $-29,374 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 122,853 | 124,375 | N/A | N/A |
| Common Stock Issued | 35,070 | 128 | 128 | 74 | 65 |
| Other Financing Activity | 0 | 0 | -297 | 0 | 0 |
| Financing Cash Flow | $35,070 | $122,981 | $124,206 | $74 | $65 |
| Beginning Cash Position | 85,586 | 69,649 | 69,649 | 69,649 | 69,649 |
| End Cash Position | 113,450 | 85,586 | 148,884 | 27,876 | 35,843 |
| Net Cash Flow | $27,864 | $15,937 | $79,235 | $-41,773 | $-33,806 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,307 | -33,726 | -22,392 | -12,921 | -4,497 |
| Capital Expenditure | -539 | -181 | -146 | -59 | -29 |
| Free Cash Flow | -13,846 | -33,907 | -22,538 | -12,980 | -4,526 |